The first FDA-approved over-the-counter birth control pill, Opill, is now available at certain retail pharmacy chains such as CVS, Walgreens, and Walmart, as well as online. It has a suggested retail price of $19.99 for a one-month supply and $49.99 for a three-month supply. A cost assistance program has been launched to provide Opill at reduced or no cost for eligible consumers, and it is suitable for most people of reproductive age to use to prevent pregnancy.
Online sales have begun for Opill, the first over-the-counter birth control pill in the US, available for purchase on Amazon, Opill.com, Walgreens, and Walmart. The pill, containing the progestin norgestrel, is 98% effective at preventing pregnancy and costs $19.99 for a month's supply. While efforts to make birth control more accessible have gained urgency following recent legal developments, potential barriers include insurance coverage and potential state restrictions.
America's first over-the-counter birth control pill, Opill, is now available online and will soon be in major pharmacies without a prescription. The progestin-only pill, priced at $49.99 for a three-month supply on its website, has been hailed as a historic milestone by advocacy and medical groups. Some anti-abortion groups equate hormonal birth control with abortion, while the FDA expressed concerns about obesity and the risk of missed doses with OTC availability. Opill, which has been safely used for five decades, is seen as lower-risk due to not containing estrogen and works by thickening cervical mucus to prevent sperm from fertilizing an egg.
The first over-the-counter birth control pill, Opill, is now available for online purchase in the US, with a suggested retail price of $19.99 for a one-month supply. This new option provides increased access to contraception, particularly benefiting those in remote areas or with limited access to reproductive health care. While the FDA's approval of Opill without an age restriction is a milestone for expanding access to contraception, concerns remain about potential state restrictions. The availability of Opill online and in stores offers more control over reproductive health choices, but there is ongoing debate about access to sexual and reproductive health care in the US.
The U.S. will soon offer over-the-counter birth control pills, sparking mixed reactions. Opill, priced at $20 for a one-month supply, is 98% effective and uses only progestin. Advocates argue for increased access to hormonal contraceptives, while critics express concerns about self-medication and the need for comprehensive women's healthcare. The availability of over-the-counter birth control coincides with discussions around women's fertility, including access to the abortion pill.
Opill, the first over-the-counter birth control pill, will be available for purchase later this month online and in pharmacies for $19.99 a month. Its approval by the FDA last July has been seen as a potential game-changer for access to birth control, eliminating the need for a doctor's prescription. However, the cost may impact accessibility, especially for those without insurance, and Opill has announced a cost-assistance program to help low-income, uninsured individuals obtain the pill at low or no cost.
The first nonprescription birth control pill, Opill, will soon be available in the United States for $19.99 a month, following FDA approval last year. It is more effective than condoms and other nonprescription methods, making it a convenient option for teenagers and women facing barriers to obtaining a prescription. Opill, originally approved for prescription use 50 years ago, is 93% effective at preventing pregnancy with typical use and has received widespread support from reproductive and adolescent health specialists, despite some opposition from certain groups.
The first over-the-counter birth control pill, Opill, is set to be available in U.S. stores, allowing women and teens to purchase it without a prescription. Manufactured by Perrigo, the one-month supply will cost about $20, and there will be no age restrictions on sales. This launch provides U.S. women with another birth control option amid legal and political battles over reproductive health, and the approval is unrelated to ongoing court battles over the abortion pill mifepristone. Despite some concerns by FDA scientists, the drug's approval has been granted, and studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.
America's first over-the-counter birth control pill, Opill, will be available in stores and online nationwide later this month, offering a new option for accessing oral contraceptive pills without a prescription. The medication, approved by the FDA in 2023, will cost $19.99 for a one-month supply in stores and $49.99 for a three-month supply, with online options available. While hailed as a major victory for reproductive rights, concerns remain about equitable access, cost, and availability, with efforts to address these issues underway. Opill uses progestin to prevent pregnancy and is seen as a significant expansion of contraceptive options in the U.S.
Opill, the first over-the-counter birth control pill in the U.S., has been shipped to retailers and will be available online and in stores later this month. It is a progestin-only pill, priced at $19.99 for a month's supply, and is 98% effective at preventing pregnancy. The FDA panel and experts have deemed it safe for use without a prescription. This option aims to provide convenient access to contraception for those who may have difficulty visiting a healthcare provider.
The first over-the-counter birth control pill in the US, Opill, has been shipped to major retailers and pharmacies, with a one-month supply costing $19.99 and a three-month supply priced at $49.99. Opill will also be available online and through select retailers, offering a six-month supply for $89.99. While it is 98% effective at preventing pregnancy when taken as directed, concerns about cost and accessibility persist, with advocacy groups urging for lower pricing. Perrigo has announced a cost assistance program for qualified low-income and uninsured individuals, and the pill may be eligible for payment or reimbursement through insurance accounts. Despite potential barriers, healthcare professionals view Opill as a positive step toward improving access to high-quality birth control.
The US FDA has approved Opill, an oral contraceptive, for over-the-counter use, making it the first nonprescription birth control pill in the country. Opill is expected to be available in early 2024 and is seen as a significant advancement in reproductive healthcare accessibility. It is a progestin-only "mini-pill" that does not contain estrogen and is about 98% effective if taken as directed. Opill can also be used for medical purposes beyond contraception. The cost and insurance coverage for Opill are still uncertain, but efforts are being made to ensure affordability and accessibility. The approval of Opill could help address unintended pregnancies, but legal challenges may arise. Overall, experts hope that the over-the-counter approval of Opill will normalize contraception and improve access to reproductive healthcare.
The U.S. Food and Drug Administration has approved the sale of the oral contraceptive Opill without a prescription, making it easier to obtain. However, health insurance plans are not required to cover the medication in its over-the-counter form, potentially limiting access for some women and girls. Opill's manufacturer, Perrigo, plans to make the pill available in major stores and online in early 2024, but insurance coverage for the pill remains uncertain. Democrats in Congress and President Joe Biden are pushing to expand access to contraception, while Perrigo is working to enlist private insurance and state Medicaid programs to offer over-the-counter Opill for free.
The US Food and Drug Administration (FDA) has approved the first over-the-counter birth control pill in the United States. The pill, called Opill, is a "mini-pill" that uses the hormone progestin. Its manufacturer, Perrigo, hailed the FDA's decision as a "milestone" and a "giant leap for women's empowerment." Opill is expected to be available in stores in early 2024. Advocates stress the importance of insurance coverage for the pill and hope it will help reduce unintended pregnancies, which account for almost half of the 6.1 million pregnancies in the US each year.
The Food and Drug Administration has approved the first over-the-counter birth-control pill, called Opill, which will significantly increase access to contraception for women across the United States.
